Target Group Inc.
CBDYDrugs in Pipeline
2
Phase 3 Programs
2
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
OTL38 | Phase 3 | Ovarian Cancer | - | - |
OTL38 for Injection | Phase 3 | Lung Neoplasms | - | - |
Frequently asked questions
What is in Target Group Inc.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in Target Group Inc.'s (CBDY) pipeline across Phase 3. Its lead program is OTL38 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Target Group Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Target Group Inc. (CBDY) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track CBDY biotech catalysts?→
Add CBDY to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Target Group Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.